DOWNLOAD DATASHEET
Research Grade Tagitanlimab
Overview
Catalog No. HV974186
Host species Humanized
Tested applications WB
Species reactivity Human
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.
Purity >95% purity as determined by SDS-PAGE.
Clonality Monoclonal
Isotype IgG1-kappa
Applications ELISA, Bioactivity: FACS, Functional assay, Research in vivo, WB
Target B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274
Purification Protein A/G purified from cell culture supernatant.
Endotoxin level Please contact the lab for this information.
Expression system Mammalian Cells
Accession Q9NZQ7
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternative name A-167, HBM-9167, KL-A1672417649-97-7
Product Usage Information
Application Dilution
WB 1:500-1:2000
Note For research use only. Not suitable for clinical or therapeutic use.
Description

Tagitanlimab (HV974186) is a research-grade recombinant antibody targeting CD1. Produced in mammalian cells with native-like glycosylation.
Highlights
  • Research Grade — For PK/PD studies, assay development, and ADA research.
  • Native Glycosylation — Mammalian expression ensures native-like patterns.

Images


SDS-PAGE
SDS-PAGE for Research Grade Tagitanlimab.

Bioactivity
Detects recombinant PDL1 (Catalog No: HV974011) in indirect ELISA.

Western blot
Western blot analysis was performed using anti-PDL1 monoclonal antibody at 1ug/mL on various samples.
Lane 1: recombinant human PDL1 (Catalog No: HV974011)
Lane 2: Negative control